欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/1816/001
药品名称Ferinject
活性成分
    • ferric carboxymaltose 50.0 mg/ml
剂型Solution for injection
上市许可持有人Vifor France, Paris La Défense Cedex France
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Croatia (HR)
    • United Kingdom (Northern Ireland) (XI)
      PL 15240/0002 - 0036
    • Germany (DE)
      2166227
    • Denmark (DK)
      Ferinject
    • Netherlands (NL)
    • Luxembourg (LU)
    • Austria (AT)
      Ferinject 50 mg Eisen/ml Injektionslösung oder Konzentrat zur Herstellung einer Infusionslösung
    • Spain (ES)
    • Portugal (PT)
    • Greece (GR)
    • Finland (FI)
    • Poland (PL)
      Ferinject
    • Latvia (LV)
    • Estonia (EE)
      FERINJECT
    • Czechia (CZ)
      Ferinject
    • Slovakia (SK)
      Ferinject
    • Ireland (IE)
    • Belgium (BE)
    • Iceland (IS)
    • France (FR)
    • Italy (IT)
    • Norway (NO)
    • Hungary (HU)
      FERINJECT 50 mg vas/ml oldatos injekció vagy infúzió
    • Bulgaria (BG)
      Ferinject
    • Cyprus (CY)
      FERINJECT 50mg/ml SOLUTION FOR INJECTION
    • Romania (RO)
      Ferinject 50 mg fer/ml solutie injectabila/perfuzabila
    • Slovenia (SI)
许可日期2007/12/09
最近更新日期2024/11/06
药物ATC编码
    • B03AC01 ferric oxide polymaltose complexes
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase